Evidence mapPaperPMID 40689155Full record

ArticlePsoriasis (Auckland, N.Z.)2025

Tobacco Smoking Was Positively Associated with Disease Relapse at week 24 and 48 Among Patients with Psoriasis Vulgaris in Shanghai: A Prospective Study.

Fanlingzi Shen, Yuning Ding, Yan Qiang, Zhen Duan, Quanruo Xu, Xiangjin Gao, Rui Zhang, Ruiping Wang

Abstract read
In one paragraph

Article in Psoriasis (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fanlingzi Shen *Clinical Research Center, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China.
Yuning Ding *Clinical Research Center, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China.ORCID 0009-0006-9470-3277
Yan Qiang *Clinical Research Center, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China.
Zhen DuanSchool of Public Health, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.
Quanruo XuSchool of Public Health, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.ORCID 0009-0005-2864-2886
Xiangjin GaoClinical Research Center, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China.ORCID 0000-0002-1793-7970
Rui ZhangClinical Research Center, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China.
Ruiping WangClinical Research Center, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China.ORCID 0000-0003-4183-5795

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Tobacco smoking is an unhealthy behavior associated with the onset, severity, and treatment response of psoriasis. However, evidence regarding the impact of tobacco smoking on the relapse of psoriasis remains limited. This study aims to examine the relapse condition in psoriasis patients and explore the association between tobacco smoking and psoriasis relapse. Patients and Methods: We conducted an observational study with 551 psoriasis patients recruited from 2022 to 2024 in Shanghai Skin Disease Hospital. A structured questionnaire and physical examination were used to collect data at baseline, week 12, week 24 and week 48. PASI50 and PASI75 were used to evaluate the improvement of psoriasis patients after treatment at week 12, and disease relapse was defined as the loss of 50% PASI improvement during clinical remission after the achievement of PASI50 or PASI75 at week 12. Results: 75.7% of the 551 psoriasis patients were males, with an average age of 45.8 years, and 282 (51.2%) were tobacco smokers. 41.2% and 61.6% of psoriasis patients with PASI50 achievement at week 12 encounter disease relapsed at week 24 and 48, respectively, while for patients with PASI75 achievement at week 12, the relapse rate was 27.6% and 51.7% at week 24 and 48, respectively. Logistic regression indicated that patients with tobacco smoking had a higher relapse rate, especially among those with PASI75 achievement at week 12. The odds ratio was 2.10 (95% CI: 1.17-3.78) and 1.84 (95% CI: 1.07-3.14) at week 24 and week 48 respectively, even after adjusting for potential confounding factors. Moreover, patients with longer smoking duration and more daily cigarette consumption had higher relapse rate. Conclusion: Tobacco smoking was positively correlated with the relapse, especially among those with longer smoking duration and more daily cigarette consumption. Therefore, patients with psoriasis should quit smoking to reduce the risk of relapse.

Indexed as

PASIpsoriasispsoriasis area severity indexrelapsetobacco smoking

Identifiers

PMID40689155
PMCPMC12273883

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.